ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the subsidy status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the subsidy recommendations, and key clinical and economic evidence which informed their deliberations.

Published on 28 Dec 2020
Last Updated on 28 Dec 2020
A- A+
Guidance Recommendations
The Ministry of Health’s Medical Technology Advisory Committee has recommended:

  • Needled acupuncture (with or without electro stimulation) performed in public healthcare institutions (PHIs) for pain reduction or functional improvement in adults aged 18 years and above as clinically appropriate for:
    • Low back pain;
    • Neck pain, including pain radiating to the neck, or from neck to shoulders.

  • It can be administered for up to 12 sessions within 3 months from treatment initiation following formal diagnosis and recommendation by a referring medical specialist in a PHI.

  • Subsequent treatment up to 12 more sessions within the next 3 months is subject to the reviewing medical specialist’s assessment of sustained pain reduction or functional improvement for the patient.

  • It shall be performed by acupuncturists registered with the Traditional Chinese Medicine Practitioners Board (TCMPB) in accordance with minimum practice standards defined by the TCM Branch of MOH.

Subsidy status

Subsidy for needled acupuncture (with or without electro stimulation) for the abovementioned criteria is applicable only for treatments performed in public healthcare institutions.


Acupuncture for adults with low back pain and neck pain (Dec 2020) Acupuncture for adults with low back pain and neck pain (Annex) (Dec 2020)